Luc Gagnon

发表

Standardised quantitative assays for anti-SARS-CoV-2 immune response used in vaccine clinical trials by the CEPI Centralized Laboratory Network: a qualification analysis.

E. Montomoli, G. Mattiuzzo, R. Raqib, 2024, The Lancet. Microbe.

Driving consistency: CEPI-Centralized Laboratory Network’s conversion factor initiative for SARS-CoV-2 clinical assays used for efficacy assessment of COVID vaccines

Pamela C. Proud, Philipa Levesque-Damphousse, Luc Gagnon, 2024, Human Vaccines & Immunotherapeutics.